We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

MicroGem

MicroGEM is democratizing molecular biology by moving molecular techniques out of conventional, highly skilled labora... read more Featured Products: More products

Download Mobile App





World's First SARS-CoV-2 Saliva PCR System for POC Delivers Results in 30 Minutes

By LabMedica International staff writers
Posted on 18 Aug 2022

The world continues to see COVID-19 cases and related deaths, with new cases and hospitalizations driven by the Omicron BA. More...

5 variant. In today's 'new normal', where activities are resuming among vaccinated and unvaccinated people, testing can help relieve the burden and anxiety about who is sick and infectious. Now, the first-of-their-kind PCR-based system and saliva test can enable fast, simple, on-the-spot detection of COVID-19 infection.

The MicroGEM Sal6830 Point of Care PCR System and SARS-CoV-2 Saliva Test from MicroGEM International (Charlottesville, VA, USA) give people timely answers about their health status, allowing them to quickly return to regular activities or immediately isolate and get care. The Sal6830 leverages MicroGEM's proprietary point of care technology, which combines enriched intact virus, thermophilic enzymatic RNA extraction, and microscale high-speed RT-PCR to capture whole virus to detect SARS-CoV-2 in under 30 minutes.

Sal6830's non-invasive saliva sampling, simple on-screen instructions, fast on-the-spot results, and portability provide an invaluable tool to quickly and accurately detect COVID-19 in settings ranging from healthcare centers, film production sets, and government and academic facilities, to mobile testing sites, retirement homes and long-term care communities. The Sal6830 SARS-CoV-2 Saliva Testing Kit's innovative cartridge design allows new targets to be added or replaced quickly, significantly reducing both assay and product development time.

The MicroGEM Sal6830 Point of Care PCR System and the MicroGEM Sal6830 SARS-CoV-2 Saliva Test recently received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). The company plans on seeking authorization to expand the test menu and ruggedize the system to address austere field conditions presented in military and disaster medicine use cases, and adapt the system for the precision medicine healthcare market with quantitative gene expression panels used as biomarkers.

"Sal6830 is transforming the 'new normal' of living and working with COVID-19 by providing an easy, convenient saliva test that eliminates the discomfort of nasal swabs," said Geoff Stein, Director of Channel Partner Sales for MicroGEM.

Related Links:
MicroGEM International 


Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Neuron-derived extracellular vesicles carry many biomarker candidates for Alzheimer’s (S Chinnathambi et al., Brain Network Disorders (2025). doi.org/10.1016/j.bnd.2024.12.006)

Neuron-Derived Extracellular Vesicles Could Improve Alzheimer’s Diagnosis

Alzheimer’s disease is becoming increasingly common as global populations age, yet effective treatments for advanced stages remain limited. Early detection is therefore critical, but current diagnostic... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.